CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Upstream Bio, Inc.

UPB
$285MMicro Cap

Next catalyst

Phase 2September 2027

Verekitug

Severe Asthma

Get an email about UPB's next catalysts

Track Upstream Bio (UPB) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 2 more upcoming events in our data (conference, Phase 2 readout).See the timeline

Catalyst Timeline

3 upcoming, 2 past

Conference

Conference Presentation

December 2026~

Upstream Bio announced participation in upcoming December 2026 investor conferences. No specific details regarding conference dates, locations, or presentation topics were provided.

Phase 2Next

Verekitug Phase 2 Est. Readout

September 2027~Verekitug396

Estimated primary completion for Verekitug trial (NCT06966479) in Severe Asthma. Topline data typically follows completion by weeks to months.

Source
Phase 2

Verekitug Phase 2 Est. Readout

October 2027~Verekitug666

Primary completion for Verekitug trial (NCT06966479) in Severe Asthma

Source

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical Preparations🇺🇸North AmericaWALTHAM52 employees
Drug Pipeline

Frequently asked questions

What is in Upstream Bio, Inc.'s drug pipeline?→

CatalystAlert tracks 2 drug candidates in Upstream Bio, Inc.'s (UPB) pipeline across Phase 2. Its lead program is Verekitug (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Upstream Bio, Inc.'s next FDA catalyst?→

Upstream Bio, Inc.'s (UPB) next tracked catalyst is a Phase 2 readout expected September 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track UPB biotech catalysts?→

Add UPB to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Upstream Bio, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply